Results 191 to 200 of about 103,481 (331)

Dopamine Modulates Striato-Frontal Functioning during Temporal Processing [PDF]

, 2011
Jahanshahi, Marjan, Jones, Catherine RG
core   +3 more sources

UB-165: A Novel Nicotinic Agonist with Subtype Selectivity Implicates the α4β2* Subtype in the Modulation of Dopamine Release from Rat Striatal Synaptosomes [PDF]

, 2000
Christopher G. V. Sharples, Sergio Kaiser, L. Soliakov, Michael J. Marks, Allan C. Collins, Mark Washburn, Emma Wright, James A. Spencer, T. Gallagher, Paul Whiteaker, Susan Wonnacott   +10 more
openalex   +1 more source

Subcutaneous Foslevodopa as Rescue Therapy for Abrupt Interruption of Oral Dopaminergic Treatment in Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Fabienne Ory‐Magne, Jean Luc Houeto, Margherita Fabbri   +2 more
wiley   +1 more source

Prolactin secreting pituitary neuroendocrine tumors treated by dopamine agonists: predictors of response. [PDF]

Front Endocrinol (Lausanne)
Mele C, Zavattaro M, Pitino R, Romanisio M, Ferrero A, Sturnia S, Catenazzi S, Rosmini F, Baldi S, Marzullo P, Aimaretti G, Prodam F, Caputo M.   +12 more
europepmc   +1 more source

Dopamine-Deficient Mice Are Hypersensitive to Dopamine Receptor Agonists [PDF]

, 2000
Douglas S. Kim, Mark S. Szczypka, Richard D. Palmiter   +2 more
openalex   +1 more source

Comparative Analysis of the Incidence, Prevalence, and Survival of 8 Types of Parkinsonism in a Population‐Based Study with 367 Million Person Years of Observation over 21 Years

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Findings are contradictory regarding changes in the incidence and prevalence of Parkinson's disease (PD) over time; data for other parkinsonian disorders are rare. Objectives To analyze temporal trends in the incidence and prevalence of eight parkinsonisms (PD, MSA, PSP, CBS, DLB, vascular parkinsonism, drug‐induced parkinsonism ...
Sacha E. Gandhi, Katherine A. Grosset, Prasanth A. Iruthayaraj, Romel Gravesande, Lance Lee, Cathal Doyle, Yoav Ben‐Shlomo, Donald G. Grosset   +7 more
wiley   +1 more source

Transcriptional Regulation of the Human PRL-Releasing Peptide (PrRP) Receptor Gene by a Dopamine 2 Receptor Agonist: Cloning and Characterization of the Human PrRP Receptor Gene and Its Promoter Region [PDF]

, 2002
Atushi Ozawa
openalex   +2 more sources

Pulmonary Fibrosis in a Patient With a Prolactinoma on Dopamine Agonists: Coincidence or Consequence. [PDF]

JCEM Case Rep
Shah R, Bal A, Arjunan D, Ghosh J, Grossman AB, Dutta P.   +5 more
europepmc   +1 more source

Basal Forebrain Volume and Concurrent Hallucinations and Mild Cognitive Impairment in Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Visual hallucinations (VH) and mild cognitive impairment (MCI) often co‐occur in Parkinson's Disease (PD). Each symptom in isolation is associated with cholinergic basal forebrain (BF) atrophy. However, it is unclear whether BF integrity relates to one symptom preferentially or to their co‐occurrence, and whether this relationship ...
Sabrina M. Adamo, Vaishali Mutreja, Marta Statucka, Batu Kaya, Taylor W. Schmitz, Anthony C. Ruocco, Melanie Cohn   +6 more
wiley   +1 more source

Inhibitory effects of dopamine agonists on pain-responsive neurons in the central nucleus of the amygdala. [PDF]

J Neurophysiol
Heuermann RJ, Gereau RW.
europepmc   +1 more source